Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01098552 · ClinicalTrials.gov registry record
Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 4,900
- Enrollment target
NCT01098552: Completed study, sponsored by Mayo Clinic.
NCT01098552 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 4,900 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01098552 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 4,900 participants
- Enrollment target
Study Summary
This research study is being done to collect regular and routine follow-up information related to the outcome of treatment for prostate cancer. This study is also being done to relate treatment outcome to measurement of substances in the blood such as prostate-specific antigen (PSA) and other markers. Also environmental and genetic factors that might be responsible for prostate cancer are being investigated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,900 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01098552
The ClinicalTrials.gov registry entry for NCT01098552 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01098552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01098552 about?
NCT01098552 is a clinical study titled "Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up". This research study is being done to collect regular and routine follow-up information related to the outcome of treatment for prostate cancer. This study is also being done to relate treatment outcome to measurement of substances in the blood such as prostate-specific antigen (PSA) and other marke...
What is the current status of trial NCT01098552?
This trial is currently completed. The enrollment target is 4,900 participants. The study started on 2010-02. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT01098552?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.